Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for banking industry professionals · Monday, December 17, 2018 · 471,343,047 Articles · 3+ Million Readers

Generic Injectables Market 2017-2022: Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts

/EIN News/ -- Dublin, Nov. 24, 2017 (GLOBE NEWSWIRE) -- The "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report has been added to Research and Markets' offering.

The global generic injectables market reached a value of more than US$ 43 Billion in 2016, exhibiting a CAGR of around 9% during 2009-2016.

Owing to the advantages offered by generic injectables, governments in various countries are supporting their manufacture. Additionally, an increase in drug shortages, especially in the US, along with patent expiry of a number of blockbuster drugs, aging population and rising prevalence of chronic as well as lifestyle diseases represent some of the other factors driving the growth of the market. According to Generic Injectables Market:

The report has segmented the market on the basis of therapeutic area as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others. Currently, the oncology segment accounts for the majority of the total market share. Further, the report has segmented the market on the basis of distribution channels covering hospitals and retail pharmacy stores. Among these, hospitals account for the largest market share. On a regional-basis, the report covers North America, Europe, Asia, Latin America, and Middle East and Africa. North America represents the largest region, accounting for more than a half of the total global share.

The report has also analysed the competitive landscape of the market with some of the key players being Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter.

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Forecast
5.5 Major Players

6 Global Generic Drug Delivery Market
6.1 Oral
6.2 Injectables
6.3 Dermal/Topical
6.4 Inhalers

7 Global Generic Injectables Market
7.1 Market Overview
7.2 Market Performance
7.3 Market Breakup by Region
7.4 Market Breakup by Therapeutic Area
7.5 Market Breakup by Distribution Channel
7.6 Market Forecast
7.7 SWOT Analysis
7.7.1 Strengths
7.7.2 Weaknesses
7.7.3 Opportunities
7.7.4 Threats
7.8 Value Chain Analysis
7.9 Porter's Five Forces Analysis
7.9.1 Overview
7.9.2 Bargaining Power of Buyers
7.9.3 Bargaining Power of Suppliers
7.9.4 Degree of Competition
7.9.5 Threat of New Entrants
7.9.6 Threat of Substitutes
7.10 Key Market Drivers and Success Factors

8 Global Generic Injectables Market: Performance of Key Regions
8.1 North America
8.2 Europe
8.3 Asia
8.4 Latin America
8.5 Middle East and Africa

9 Market by Therapeutic Area
9.1 Oncology
9.2 Anaesthesia
9.3 Anti-infectives
9.4 Parenteral Nutrition
9.5 Cardiovascular

10 Market by Distribution Channel
10.1 Hospitals
10.2 Retail Pharmacy Stores

11 Global Generic Injectable Market: Competitive Landscape
11.1 Competitive Structure
11.2 Market Breakup by Key Players

12 Generic Injectable Manufacturing Process
12.1 Product Overview
12.2 Detailed Process Flow (Injectable)
12.3 Various Types of Unit Operations Involved
12.4 Mass Balance and Raw Material Requirements

13 Project Details, Requirements and Costs Involved
13.1 Land Requirements and Expenditures
13.2 Construction Requirements and Expenditures
13.3 Plant Machinery
13.4 Machinery Pictures
13.5 Raw Material Requirements and Expenditures
13.6 Packaging Requirements and Expenditures
13.7 Transportation Requirements and Expenditures
13.8 Utility Requirements and Expenditures
13.9 Manpower Requirements and Expenditures
13.10 Other Capital Investments

14 Loans and Financial Assistance

15 Project Economics
15.1 Capital Cost of the Project
15.2 Techno-Economic Parameters
15.3 Product Pricing and Margins Across Various Levels of the Supply Chain
15.4 Taxation and Depreciation
15.5 Income Projections
15.6 Expenditure Projections
15.7 Financial Analysis
15.8 Profit Analysis

16 Key Player Profiles

For more information about this report visit

                    CONTACT: Research and Markets
                             Laura Wood, Senior Manager
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             Related Topics: Infusions and Injectables 

Primary Logo

Powered by EIN News

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release